ARNA Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 01:00):

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide...

Stats
Tagesvolumen	0.00
Durchschnittsvolumen	1.47M
Marktkapitalisierung	0.00
EPS	$0 ( 2022-05-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.86
ATR14	$1.142 (1.14%)

Insider Trading

Date	Person	Action	Amount	type
2022-03-11	Nova Tina Susan	Sell	17 776	Common Stock
2022-03-11	Nova Tina Susan	Sell	3 067	Common Stock
2022-03-11	Nova Tina Susan	Sell	4 800	Stock Option (right to buy)
2022-03-11	Nova Tina Susan	Sell	15 000	Stock Option (right to buy)
2022-03-11	Nova Tina Susan	Sell	5 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 416 073 \| Sell: 1 553 839

Volumen Korrelation

Lang: 0.35 (neutral)

Kurz: 0.92 (very strong)

Signal:(78.914) Expect same movement, but be aware

Arena Pharmaceuticals Inc Korrelation

10 Am meisten positiv korreliert
LWAC	0.991
SRAC	0.943
FANH	0.918
MYRG	0.914
TSBK	0.91
TIG	0.908
ALTR	0.904
MNST	0.897
LOPE	0.892
PTMN	0.891

10 Am meisten negativ korreliert
NKTR	-0.97
AGLE	-0.968
INGN	-0.964
CNSP	-0.962
FULC	-0.95
SMSI	-0.947
UPLD	-0.945
ZI	-0.937
CCSI	-0.936
NRBO	-0.933

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Arena Pharmaceuticals Inc Korrelation - Währung/Rohstoff

-0.43
( neutral )

0.35
( neutral )

0.51
( weak )

-0.21
( neutral )

0.23
( neutral )

0.37
( neutral )

Arena Pharmaceuticals Inc Finanzdaten

Annual	2021
Umsatz:	$54 000.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-11.26

FY	2021
Umsatz:	$54 000.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-11.26

FY	2020
Umsatz:	$319 000
Bruttogewinn:	$319 000 (100.00 %)
EPS:	$-7.39

FY	2019
Umsatz:	$806.43M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$7.99

Financial Reports:

No articles found.

Arena Pharmaceuticals Inc

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.